News

(Harleysville, PA; April. 28, 2021) – We could not be more pleased to become part of a global leader in the life sciences regulatory and compliance industry. Joining PLG is exciting both for DSI as a business and for our clients, who will now have access to additional specialist expertise […]

DSI announced today that it will be actively engaged in partnering meetings during the BIO International Convention. The 2021 BIO International Convention will transition to a virtual event format, BIO Digital. This virtual gathering of the global biotech industry provides access to partners via BIO One-on-One Partnering and educational resources. […]

DSI will be attending the AAPS PharmSci 360 Convention from October 17-20, 2021. Our team will be conducting virtual meetings this year. Please contact us to set up a time to meet. About DSI DSI is a full-service regulatory drug development consulting firm for pharmaceuticals, biologics and new drug and […]

DSI’s recent acquisition by Paris-Based, Product Life Group (PLG), has opened the company to further expand into the European market. We hold prior experience in Europe and ROW but are excited to explore more opportunities in these markets. The addition of PLG’s resources and support will allow DSI to dive […]

Each year, healthcare, pharmaceutical, and biotechnology executives attend the JP Morgan Healthcare Conference, some to tout recent developments, others just to bounce from session to session. We work hard at DSI to make life science companies better at what you do in the Chemistry, Manufacturing and Controls (CMC) areas. We’ve […]

DESIGN SPACE INPHARMATICS (DSI) ANNOUNCES APPOINTMENT OF BEN LUTS AS DIRECTOR OF BUSINESS DEVELOPMENT (Harleysville, PA; February 1, 2022) – Design Space InPharmatics (DSI), a full-service CMC consulting firm focused on providing pharmaceutical attributes, regulatory affairs, and drug discovery and development consulting services, is delighted to announce today the appointment […]